Improving outcomes of liver retransplantation: an analysis of trends and the impact of Hepatitis C infection
- PMID: 18211509
- DOI: 10.1111/j.1600-6143.2007.02082.x
Improving outcomes of liver retransplantation: an analysis of trends and the impact of Hepatitis C infection
Abstract
Retransplantation (RT) in Hepatitis C (HCV) patients remains controversial.
Aims: To study trends in RT and evaluate the impact of HCV status in the context of a comprehensive recipient and donor risk assessment. The UNOS database between 1994 and October 2005 was utilized to analyze 46 982 LT and RT. Graft and patient survival along with patient and donor characteristics were compared for 2283 RT performed in HCV and non-HCV patients during 1994-1997, 1998-2001 and 2002-October 2005. Overall HCV prevalence at RT increased from 36% in the initial period to 40.6% after 2002. In our study group, 1-year patient and graft survival post-RT improved over the same time intervals from 65.0% to 70.7% and 54.87% to 65.8%, respectively. HCV was only associated with decreased patient and graft survival with a retransplant (LT-RT) interval (RI) >90 days. Independent predictors of mortality for RT with RI >90 days were patient age, MELD score >25, RI <1 year, warm ischemia time > or =75 min and donor age > or =60 (significant for HCV patients only). Outcomes of RT are improving, but can be optimized by weighing recipient factors, anticipation of operative factors and donor selection.
Similar articles
-
Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival.Liver Transpl. 2007 Dec;13(12):1717-27. doi: 10.1002/lt.21292. Liver Transpl. 2007. PMID: 18044750
-
A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.Ann Surg. 2001 Sep;234(3):384-93; discussion 393-4. doi: 10.1097/00000658-200109000-00012. Ann Surg. 2001. PMID: 11524591 Free PMC article.
-
Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.World J Gastroenterol. 2016 May 14;22(18):4547-58. doi: 10.3748/wjg.v22.i18.4547. World J Gastroenterol. 2016. PMID: 27182164 Free PMC article.
-
Retransplantation for recurrent hepatitis C: positive aspects.Liver Transpl. 2003 Nov;9(11):S67-72. doi: 10.1053/jlts.2003.50249. Liver Transpl. 2003. PMID: 14586899 Review.
-
Retransplantation in patients with hepatitis C recurrence after liver transplantation.J Hepatol. 2010 Nov;53(5):962-70. doi: 10.1016/j.jhep.2010.06.006. Epub 2010 Jul 22. J Hepatol. 2010. PMID: 20800307 Review.
Cited by
-
Liver transplantation and hepatitis C.Int J Hepatol. 2012;2012:686135. doi: 10.1155/2012/686135. Epub 2012 Jul 26. Int J Hepatol. 2012. PMID: 22900194 Free PMC article.
-
Emergency, ABO-Incompatible Living Donor Liver Re-Transplantation for Graft Failure Complicated by Pneumonia-Associated Sepsis.J Clin Med. 2023 Jan 31;12(3):1110. doi: 10.3390/jcm12031110. J Clin Med. 2023. PMID: 36769757 Free PMC article.
-
Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.Am J Transplant. 2010 Jun;10(6):1420-7. doi: 10.1111/j.1600-6143.2010.03126.x. Epub 2010 May 10. Am J Transplant. 2010. PMID: 20486907 Free PMC article.
-
Liver physiology and liver diseases in the elderly.World J Gastroenterol. 2013 Dec 14;19(46):8459-67. doi: 10.3748/wjg.v19.i46.8459. World J Gastroenterol. 2013. PMID: 24379563 Free PMC article. Review.
-
Transplant center volume and outcomes after liver retransplantation.Am J Transplant. 2009 Feb;9(2):309-17. doi: 10.1111/j.1600-6143.2008.02488.x. Epub 2008 Dec 15. Am J Transplant. 2009. PMID: 19120081 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical